A detailed history of Jaffetilchin Investment Partners, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Jaffetilchin Investment Partners, LLC holds 505 shares of DXCM stock, worth $40,420. This represents 0.0% of its overall portfolio holdings.

Number of Shares
505
Previous 3,124 83.83%
Holding current value
$40,420
Previous $354,000 90.68%
% of portfolio
0.0%
Previous 0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$64.0 - $116.06 $167,616 - $303,961
-2,619 Reduced 83.83%
505 $33,000
Q2 2024

Jul 30, 2024

SELL
$110.31 - $140.45 $61,773 - $78,652
-560 Reduced 15.2%
3,124 $354,000
Q1 2024

May 16, 2024

SELL
$114.22 - $140.1 $8,338 - $10,227
-73 Reduced 1.94%
3,684 $510,000
Q4 2023

Feb 13, 2024

SELL
$75.49 - $124.16 $10,568 - $17,382
-140 Reduced 3.59%
3,757 $466,000
Q3 2023

Nov 13, 2023

SELL
$86.06 - $137.93 $16,695 - $26,758
-194 Reduced 4.74%
3,897 $363,000
Q2 2023

Aug 15, 2023

SELL
$112.47 - $130.98 $15,070 - $17,551
-134 Reduced 3.17%
4,091 $525,000
Q1 2023

May 11, 2023

SELL
$104.0 - $122.92 $6,240 - $7,375
-60 Reduced 1.4%
4,225 $490,000
Q4 2022

Feb 10, 2023

SELL
$84.98 - $122.67 $56,341 - $81,330
-663 Reduced 13.4%
4,285 $485,000
Q3 2022

Nov 14, 2022

SELL
$76.35 - $94.18 $51,307 - $63,288
-672 Reduced 11.96%
4,948 $399,000
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $286,101 - $559,201
4,208 Added 298.02%
5,620 $419,000
Q1 2022

May 13, 2022

BUY
$94.08 - $130.2 $9,502 - $13,150
101 Added 7.7%
1,412 $440,000
Q4 2021

Feb 17, 2022

SELL
$129.87 - $162.82 $15,584 - $19,538
-120 Reduced 8.39%
1,311 $704,000
Q3 2021

Oct 25, 2021

SELL
$106.71 - $143.18 $533 - $715
-5 Reduced 0.35%
1,431 $783,000
Q2 2021

Aug 09, 2021

SELL
$80.99 - $107.93 $23,082 - $30,760
-285 Reduced 16.56%
1,436 $613,000
Q1 2021

May 10, 2021

BUY
$84.79 - $104.74 $4,409 - $5,446
52 Added 3.12%
1,721 $619,000
Q4 2020

Feb 12, 2021

BUY
$78.0 - $104.5 $130,182 - $174,410
1,669 New
1,669 $617,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Jaffetilchin Investment Partners, LLC Portfolio

Follow Jaffetilchin Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jaffetilchin Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jaffetilchin Investment Partners, LLC with notifications on news.